SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic.
SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic.
The company is focused on two lead programs in …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
$2 million gene therapy cures require a financing model
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
Novo underwhelmed by drug it once fought Pfizer for
Antogen Secures Seed Financing to Advance Next-Generation Immune Surveillance Diagnostics
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a
City Therapeutics raises $99.5M Series B to advance three RNAi candidates into the clinic and expand its delivery platform beyond…
Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's…
Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.
Full-Life Technologies gets $150M; Quince finds a new life; China biotech gets $50M; SERB Pharmaceuticals buys rights to Hansa…
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
